P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 22 September 2018 | 2:58 pm

Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness

In the Phase III RAINBOW study, despite marginally missing statistical significance for the primary endpoint of demonstrating superiority of Lucentis ® to laser surgery, more ...

Published 22 September 2018 | 2:58 pm

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD

Pre-specified analysis provides insight into maintenance treatment effectiveness with like-for-like comparison of brolucizumab versus aflibercept over entire week 36 to 48 more ...

Published 22 September 2018 | 2:46 am

Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes

Bagsværd, Denmark, 20 September 2018 - Novo Nordisk today announced the headline results from PIONEER 10, a phase 3a trial with oral semaglutide vs once-weekly more ...

Published 21 September 2018 | 9:04 pm

SMART MARATHON NUTRITION FOR ROOKIES

You get out of your body what you put in, so fuel it well with these tips from runner and Abbott dietitian Pam Nisevich Bede. more ...

Published 21 September 2018 | 8:14 pm

The time is now for lung cancer patients

Lung cancer remains, by far, the leading cause of cancer death globally, but we believe we are at a turning point. To mark the start of the IASLC 19th World Conference on more ...

Published 21 September 2018 | 8:14 pm

Power to patients: the role of scientific literacy

Andrew is the Manager of Clinical Research with Lung Cancer Alliance (LCA). His role is to connect people to clinical trials. Prior to joining LCA, Andrew worked as a cancer more ...

Published 21 September 2018 | 5:52 pm

Investor Update

CHMP recommends EU approval for subcutaneous formulation of RoActemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis more ...

Published 21 September 2018 | 3:38 pm

Inside the Open Lab

The Tres Cantos Open Lab offers top international scientists and academics the opportunity to pursue their own projects as part of an integrated team. more ...

Published 21 September 2018 | 3:27 pm

GSK and Tres Cantos Open Lab Foundation announce additional £5m funding for open innovation research in diseases impacting the developing world

GSK and the Tres Cantos Open Lab Foundation today announced an additional £5m in GSK funding to support the Foundation's research and development programmes in more ...

Published 21 September 2018 | 2:13 pm

Investor Update

Roche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia Positive CHMP more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018